tisotumab vedotin fda label

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
tisotumab vedotin fda label	1.47	0.9	1378	61	27
tisotumab	0.11	0.5	5999	40	9
vedotin	1.85	0.9	2527	37	7
fda	1.06	0.7	6116	99	3
label	0.96	0.1	1845	26	5

Keyword	CPC	PCC	Volume	Score
tisotumab vedotin fda label	1.71	0.2	3481	36
enfortumab vedotin fda label	0.31	0.6	3671	20
tisotumab vedotin j code	1.8	0.1	202	15
tisotumab vedotin clinical trials	1	0.7	9194	4
tisotumab vedotin package insert	0.78	0.3	8941	86
tisotumab vedotin ema approval	0.69	0.2	2721	7
tisotumab vedotin-tftv tivdak	0.62	0.5	2897	30
tisotumab vedotin-tftv	1.46	0.7	351	14
tisotumab vedotin empfehlung deutschland	0.1	0.7	9496	6
tisotumab vedotin cervix zulassung	0.81	0.3	4923	59
polatuzumab vedotin fda label	1.66	0.5	4245	12
target antigen for tisotumab vedotin	1.83	0.5	4520	19
tisotumab vedotin ocular toxicity	1.41	0.4	3053	98
tisotumab vedotin mechanism of action	1.76	0.4	1446	58
tisotumab vedotin cervical cancer	1.63	0.9	4034	39
tisotumab vedotin cervix zulassung ema	1.18	0.9	1784	92
tisotumab vedotin cancer ovaires	0.59	0.1	3282	79
enfortumab vedotin fda approval history	0.8	0.1	7361	64
tisotumab vedotin head and neck	0.49	0.4	1159	11
enfortumab vedotin pembrolizumab fda	1.33	0.6	2584	48
enfortumab vedotin fda approval	1.4	0.4	7699	86